Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Zhejiang Cancer Hospital"
Count: 326
Selected: 0
NCT IDTitle
NCT06078930Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes Mechanisms
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT05651802PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients
NCT05794841Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract
NCT02992067CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
NCT06173466Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone
NCT06350162Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLC
NCT06349044A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
NCT06253078Ciprofol EC50 for Inducing Loss of Consciousness in Elderly Patients
NCT06308939Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical Trial
NCT06300489Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer
NCT06292689A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
NCT06272214Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
NCT06254066Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast Cancer
NCT05212064HFNC and Hypoxia/Desaturation During Radiofrequency Ablation Under Moderate Sedation: A Randomized Clinical Trial
NCT05489926A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
NCT06214195The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
NCT06199882SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma
NCT06195683Serplulimab for Patients With Non-small Cell Lung Cancer (NSCLC) With TPS ≥ 50%: a Prospective, Single-center, Single-arm Phase 2 Study.
NCT06195670Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
NCT06190639A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
NCT05103293PTC Guiding Neoadjuvant Treatment in Breast Cancer
NCT06178926Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation
NCT05298319The 90% Effective Flow of High Flow Nasal Oxygenation (HFNO) During Sedated Bronchoscopy
NCT05448638Transversus Thoracic Muscle Plane Combined With Pectoral Nerves Block for Breast Cancer Surgery
NCT06140576The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.
NCT06134011A Multi-omics-based Metabolic Typing Study of Gastric Cancer
NCT06133088Dalpiciclib Combination With Fulvestrant and Compound Gossyfol Acetate Tablets in Women With CDK4/6 Inhibitor-refractory HR-positive HER-2 Negtive Metastatic Breast Cancer: a Phase 2 Clinical Trial.
NCT05557578GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence
NCT06086197A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCL
NCT06103214The Effects of Hemodilution Methods in Patients Undergoing Primary Debulking Gynaecological Surgery
NCT06092645Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct Adenocarcinoma
NCT05290090ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL
NCT06055816Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
NCT05228496A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC
NCT06048289Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy
NCT04119674Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
NCT06046963Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites
NCT060063383D Printed Models for Liver Surgery
NCT05992597ZR2 Sequential Immunochemotherapy for Newly Treated MCL
NCT04790409Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations
NCT06031597Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy
NCT05920863Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors
NCT05991947Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer
NCT05985577Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics
NCT05974085XPO-1 in Combination With RCHOP for DH/TH Lymphoma
NCT05971199Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma
NCT04808752Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases
NCT05963087Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer
NCT05958849Advanced Pancreatic Cancer